The expression of interleukin-12 is increased by MAP kinase phosphatase-1 through a mechanism related to interferon

Riku Korhonen1, Noora Huotari, Tuija Hömmö

  • 1The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland. riku.korhonen@uta.fi

Molecular Immunology
|April 3, 2012
PubMed

Insights

Mitogen-activated protein kinase phosphatase-1 (MKP-1) positively regulates Interleukin-12 (IL-12) expression by enhancing Interferon Regulatory Factor 1 (IRF1). This finding suggests MKP-1 supports Th1 immune responses and anti-microbial defense.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Mitogen-activated protein kinase phosphatase-1 (MKP-1) is a nuclear phosphatase that typically inhibits p38 MAPK activity.
  • MKP-1 deficiency is known to cause excessive innate immunity and inflammatory gene expression.
  • The role of MKP-1 in regulating specific cytokine expression, such as IL-12, was previously unclear.

Purpose of the Study:

  • To investigate the role of MKP-1 in the regulation of Interleukin-12 (IL-12) expression in macrophages.
  • To elucidate the molecular mechanisms by which MKP-1 influences IL-12 production and Th1 immune responses.

Main Methods:

  • Utilized primary mouse peritoneal macrophages (PMs) and bone marrow-derived macrophages from MKP-1 deficient and wild-type mice.
  • Employed lipopolysaccharide (LPS) stimulation to induce inflammatory responses.
  • Used pharmacologic inhibitors (BIRB 796, SB 202190) of p38 MAPK and siRNA for Interferon Regulatory Factor 1 (IRF1) silencing.

Main Results:

  • LPS-induced IL-12p40 expression was significantly lower in MKP-1 deficient macrophages compared to wild-type, while TNF expression was elevated.
  • Inhibition of p38 MAPK by pharmacologic agents enhanced LPS-induced IL-12p40 production.
  • IRF1 was identified as a key regulator of IL-12p40 expression, and its expression was modulated by MKP-1 and p38 MAPK activity.

Conclusions:

  • MKP-1 acts as a positive regulator of IL-12 expression, contrasting with its known inhibitory role on p38 MAPK.
  • MKP-1 enhances IL-12 expression by promoting IRF1 expression, thereby supporting Th1-type immune responses.
  • These findings highlight MKP-1's critical role in anti-microbial defense through the regulation of IRF1 and IL-12.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...